Cutera Announces Voluntarily Delisting from Nasdaq
Cutera (CUTR) has announced its voluntary decision to delist its common stock from the Nasdaq Global Select Market. The company plans to file a Form 25 with the SEC around March 20, 2025, with the delisting expected to become effective near March 30, 2025.
Following the delisting, Cutera intends to file a Form 15 to indefinitely suspend its SEC reporting obligations, including Annual Reports (10-K), Quarterly Reports (10-Q), and Current Reports (8-K). The company has not arranged for alternative listing or registration on another national securities exchange, and there is no guarantee of a future public trading market for its common stock.
Cutera (CUTR) ha annunciato la sua decisione volontaria di ritirare le proprie azioni ordinarie dal Nasdaq Global Select Market. L'azienda prevede di presentare un Modulo 25 alla SEC intorno al 20 marzo 2025, con il ritiro che dovrebbe diventare efficace intorno al 30 marzo 2025.
Dopo il ritiro, Cutera intende presentare un Modulo 15 per sospendere indefinitamente i suoi obblighi di reporting presso la SEC, inclusi i Rapporti Annuali (10-K), i Rapporti Trimestrali (10-Q) e i Rapporti Correnti (8-K). L'azienda non ha previsto un'altra quotazione o registrazione su un'altra borsa valori nazionale e non c'è alcuna garanzia di un futuro mercato di scambio pubblico per le sue azioni ordinarie.
Cutera (CUTR) ha anunciado su decisión voluntaria de retirar sus acciones ordinarias del Nasdaq Global Select Market. La empresa planea presentar un Formulario 25 a la SEC alrededor del 20 de marzo de 2025, con la deslistación que se espera que sea efectiva cerca del 30 de marzo de 2025.
Tras la deslistación, Cutera tiene la intención de presentar un Formulario 15 para suspender indefinidamente sus obligaciones de reporte ante la SEC, incluidos los Informes Anuales (10-K), Informes Trimestrales (10-Q) e Informes Actuales (8-K). La empresa no ha organizado una cotización o registro alternativo en otra bolsa de valores nacional, y no hay garantía de un futuro mercado de negociación pública para sus acciones ordinarias.
Cutera (CUTR)는 Nasdaq Global Select Market에서 자사의 보통주를 상장 폐지하기로 자발적으로 결정했다고 발표했습니다. 회사는 2025년 3월 20일 경에 SEC에 Form 25를 제출할 계획이며, 상장 폐지는 2025년 3월 30일 경에 효력이 발생할 것으로 예상됩니다.
상장 폐지 이후, Cutera는 SEC 보고 의무를 무기한 중단하기 위해 Form 15를 제출할 예정이며, 여기에는 연례 보고서(10-K), 분기 보고서(10-Q) 및 현재 보고서(8-K)가 포함됩니다. 회사는 다른 국가 증권 거래소에 대한 대체 상장이나 등록을 계획하지 않았으며, 보통주에 대한 향후 공개 거래 시장이 보장되지 않습니다.
Cutera (CUTR) a annoncé sa décision volontaire de retirer ses actions ordinaires du Nasdaq Global Select Market. L'entreprise prévoit de déposer un formulaire 25 auprès de la SEC aux alentours du 20 mars 2025, avec un retrait qui devrait devenir effectif vers le 30 mars 2025.
Suite au retrait, Cutera a l'intention de déposer un formulaire 15 pour suspendre indéfiniment ses obligations de reporting auprès de la SEC, y compris les rapports annuels (10-K), les rapports trimestriels (10-Q) et les rapports actuels (8-K). L'entreprise n'a pas prévu d'autre cotation ou enregistrement sur une autre bourse nationale, et il n'y a aucune garantie d'un futur marché de négociation publique pour ses actions ordinaires.
Cutera (CUTR) hat bekannt gegeben, dass es freiwillig beschlossen hat, seine Stammaktien vom Nasdaq Global Select Market abzuziehen. Das Unternehmen plant, um den 20. März 2025 ein Formular 25 bei der SEC einzureichen, wobei die Abmeldung voraussichtlich um den 30. März 2025 wirksam werden soll.
Nach der Abmeldung beabsichtigt Cutera, ein Formular 15 einzureichen, um seine Berichtspflichten gegenüber der SEC unbefristet auszusetzen, einschließlich der Jahresberichte (10-K), Quartalsberichte (10-Q) und aktuellen Berichte (8-K). Das Unternehmen hat keine alternative Listung oder Registrierung an einer anderen nationalen Wertpapierbörse organisiert, und es gibt keine Garantie für einen zukünftigen öffentlichen Handelsmarkt für seine Stammaktien.
- None.
- Voluntary delisting from Nasdaq Global Select Market
- No alternative exchange listing arranged
- Loss of public trading market accessibility
- Suspension of SEC reporting transparency
The Company has not arranged for listing or registration of the common stock on another national securities exchange or for quotation in a quotation medium and cannot guarantee that any public market for trading the common stock will exist now or in the future.
About Cutera, Inc.
Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.
Safe Harbor Statement
Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange Act. These statements include but are not limited to express or implied statements regarding various matters including, but not limited to, statements regarding: the Company’s intention to file a Form 25 with the SEC to effect the voluntary delisting of the Common Stock on or about March 20, 2025 and to file a Form 15 with the SEC thereafter to suspend the Company’s Exchange Act reporting obligations; and the potential quotation of the common stock in a quotation medium. In some cases, you can identify forward-looking statements by the use of words such as, but not limited to, “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee” or variations of these terms and similar expressions or the negative of these terms or similar expressions. Forward-looking statements are based on management’s current expectations and beliefs and are subject to risks and uncertainties, which are difficult to predict and may cause the Company’s actual results to differ materially from the express or implied forward-looking statements herein. These forward-looking statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are several risks, uncertainties, and other important factors, many of which are beyond the Company’s control, that could cause its actual results to differ materially from the forward-looking statements, including risks involved with the timing and outcome of the Company’s current proceedings under Chapter 11 (the “Chapter 11 Cases”) and the Company’s filing for relief under Chapter 11; the impact of the Chapter 11 Cases on the listing of the Company’s securities on Nasdaq; as well as the other risks described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other documents filed from time to time with the SEC by the Company.
All statements made in this press release are made only as of the date of this report. Accordingly, undue reliance should not be placed on forward-looking statements. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If the Company updates one or more forward-looking statements, no inference should be drawn that it will make additional updates concerning those or other forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310151863/en/
Cutera Media:
Rose Temple / Evelyn Bubb
CuteraComms@fticonsulting.com
Source: Cutera, Inc.
FAQ
When will Cutera (CUTR) be delisted from Nasdaq?
What happens to Cutera's SEC reporting requirements after delisting?
Will Cutera (CUTR) stock be tradable after Nasdaq delisting?
Is Cutera's delisting from Nasdaq voluntary or forced?
